Calidi Biotherapeutics, Inc. (CLDI) stock
CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
$0.56−0.04 (-7.07%)
Close on Nov 17, 2026Market cap $1.45MP/E –Yield –
Calidi Biotherapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Calidi Biotherapeutics's profit margin for the twelve months ending Dec 31, 2022 was -56504.4%. For fiscal 2022 it was -56504.4%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -56504.4% | – |
See a number that looks wrong?